Close Menu

Phenotypic screening is once again popular at many large pharmaceutical companies, as the targeted drug discovery approach is being considered too limiting in certain ways, says Joanne Kotz at SciBX. "Phenotypic screens used to be the mainstay of drug development," Kotz says. Since the 1980s, advances in molecular biology and genomics have led drug companies to use targeted screening method to develop drugs.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.